ADMS
Adamas Pharmaceuticals, Inc.
ADMS
ADMS
Delisted
ADMS was delisted on the 23rd of November, 2021.
98 hedge funds and large institutions have $150M invested in Adamas Pharmaceuticals, Inc. in 2019 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 30 increasing their positions, 30 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
98
Holders Change
+1
Holders Change %
+1.03%
% of All Funds
2.12%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.07%
New
19
Increased
30
Reduced
30
Closed
18
Calls
$637K
Puts
$786K
Net Calls
-$149K
Net Calls Change
-$2.16M
Top Buyers
| 1 |
AC
Armistice Capital
New York
|
+$14.8M |
| 2 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$7M |
| 3 |
Millennium Management
New York
|
+$3.83M |
| 4 |
DAM
Deltec Asset Management
New York
|
+$2.14M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.75M |
Top Sellers
| 1 |
Invesco
Atlanta,
Georgia
|
-$18M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$10.8M |
| 3 |
AllianceBernstein
Nashville,
Tennessee
|
-$8.37M |
| 4 |
Morgan Stanley
New York
|
-$3.91M |
| 5 |
Renaissance Technologies
New York
|
-$2.81M |
